Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ulbrich

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2003
HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemiaM Kovár, T Mrkvan, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 12, 2002
Differences in the intracellular fate of free and polymer-bound doxorubicinOndrej Hovorka, M St'astný, T Etrych, et al.
Biomaterials|July 1, 1989
Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitroB Rihova, M Bilej, V Vetvicka, et al.
Annals of the New York Academy of Sciences|June 9, 1998
HPMA-based biodegradable hydrogels containing different forms of doxorubicin. Antitumor effects and biocompatibilityB Ríhová, J Srogl, M Jelínková, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 22, 1998
Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer-doxorubicin conjugates directed against different T-cell surface antigensM Jelínková, J Strohalm, D Plocová, et al.
Physiological Research|October 9, 2015
Nanotherapeutics shielded with a pH responsive polymeric layerL Kostka, V Šubr, R Laga, et al.
Mycoses|January 1, 1996
[Allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF): clinical significance, diagnosis and therapy]K D Paul, W Leupold, R Blaschke-Hellmessen, et al.
British Journal of Cancer|June 1, 1991
N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 miceL W Seymour, K Ulbrich, S R Wedge, et al.
Gene Therapy|April 21, 2001
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodiesK D Fisher, Y Stallwood, N K Green, et al.
Bioconjugate Chemistry|July 18, 2000
Steric stabilization of poly-L-Lysine/DNA complexes by the covalent attachment of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]D Oupický, K A Howard, C Konák, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2003
HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemiaM Kovár, T Mrkvan, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 12, 2002
Differences in the intracellular fate of free and polymer-bound doxorubicinOndrej Hovorka, M St'astný, T Etrych, et al.
Biomaterials|July 1, 1989
Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitroB Rihova, M Bilej, V Vetvicka, et al.
Annals of the New York Academy of Sciences|June 9, 1998
HPMA-based biodegradable hydrogels containing different forms of doxorubicin. Antitumor effects and biocompatibilityB Ríhová, J Srogl, M Jelínková, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 22, 1998
Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer-doxorubicin conjugates directed against different T-cell surface antigensM Jelínková, J Strohalm, D Plocová, et al.
Physiological Research|October 9, 2015
Nanotherapeutics shielded with a pH responsive polymeric layerL Kostka, V Šubr, R Laga, et al.
Mycoses|January 1, 1996
[Allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF): clinical significance, diagnosis and therapy]K D Paul, W Leupold, R Blaschke-Hellmessen, et al.
British Journal of Cancer|June 1, 1991
N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 miceL W Seymour, K Ulbrich, S R Wedge, et al.
Gene Therapy|April 21, 2001
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodiesK D Fisher, Y Stallwood, N K Green, et al.
Bioconjugate Chemistry|July 18, 2000
Steric stabilization of poly-L-Lysine/DNA complexes by the covalent attachment of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]D Oupický, K A Howard, C Konák, et al.
Pageof 10